Stay updated on Pembrolizumab + Nab-Paclitaxel in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab + Nab-Paclitaxel in NSCLC Clinical Trial page.

Latest updates to the Pembrolizumab + Nab-Paclitaxel in NSCLC Clinical Trial page
- Check6 days agoChange DetectedThe page shows a revision update from v3.5.3 to v3.5.4, signaling a deployment/build update. No study content or parameters appear to be modified.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedRevision: v3.5.3 has replaced Revision: v3.5.2 as the page version label, indicating a new site release; no study information or visible content appears to be affected.SummaryDifference0.1%

- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedSite revision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check63 days agoChange DetectedAdded Revision: v3.5.0. Removed Lung cancer, related topics: MedlinePlus Genetics, and Revision: v3.4.3 from the related topics.SummaryDifference0.2%

- Check70 days agoChange DetectedLung cancer is added as a related topic and MedlinePlus Genetics link appears; the site revision was updated from v3.4.2 to v3.4.3.SummaryDifference0.2%

- Check77 days agoChange DetectedRemoved the related topics links 'Lung Cancer' and 'MedlinePlus Genetics' from the page. These related topics are navigation aids and are not part of the study details.SummaryDifference0.2%

Stay in the know with updates to Pembrolizumab + Nab-Paclitaxel in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab + Nab-Paclitaxel in NSCLC Clinical Trial page.